Vanguard Group Inc Deciphera Pharmaceuticals, Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DCPH
# of Institutions
177Shares Held
59.6MCall Options Held
5.3KPut Options Held
27.6K-
Black Rock Inc. New York, NY5.99MShares$00.0% of portfolio
-
Armistice Capital, LLC New York, NY5.9MShares$01.26% of portfolio
-
Redmile Group, LLC San Francisco, CA5.3MShares$03.28% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.13MShares$01.67% of portfolio
-
State Street Corp Boston, MA3.1MShares$00.0% of portfolio
About Deciphera Pharmaceuticals, Inc.
- Ticker DCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,822,100
- Description
- Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...